Form 4: Surgery Partners CFO Receives Restricted Stock Awards

David T. Doherty, CFO of Surgery Partners, Inc., was granted restricted stock awards on March 4, 2025, according to a Form 4 filing.

Summary

• David T. Doherty, the Chief Financial Officer of Surgery Partners, Inc., received restricted stock awards on March 4, 2025.
• The filing, a Form 4, details changes in beneficial ownership.
• Two types of restricted stock awards (RSAs) were granted.
• 33,613 RSAs vest in three equal annual installments starting on the first anniversary of the grant date.
• 15,126 RSAs vest on the first anniversary of the grant date.
• The price for both RSA grants was $23.8.
• Following the transaction, Doherty directly owns 157,601 shares of common stock.
• Jennifer Baldock, Attorney-in-Fact, signed the document on March 6, 2025.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing related to executive compensation. It's neutral in tone and doesn't inherently indicate positive or negative sentiment, but the granting of RSAs is generally viewed as a positive incentive for management.

Positives

• The grant of restricted stock awards aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of executive compensation and are common in the healthcare industry. The granting of restricted stock is a typical method to incentivize and retain key executives.

Comparison to Industry Standards

• Restricted stock awards are a common form of executive compensation across various industries, including healthcare.
• Companies like HCA Healthcare and Tenet Healthcare also utilize equity-based compensation to align executive interests with shareholder value.
• The vesting schedules and grant sizes are generally benchmarked against peer companies to ensure competitiveness.

Stakeholder Impact

• Shareholders may view the grant of restricted stock as a positive sign, aligning management's interests with the company's long-term performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Surgery Partners, SGRY, Restricted Stock Awards, Form 4, David T. Doherty, CFO, Beneficial Ownership, Equity Compensation